The harmful effects of subarachnoid hemorrhage on extracerebral organs

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Sheng ^a,b   Li, Qian ^c   Wu, Haijian ^a   Krafft, Paul R ^b   Wang, Zhen ^a   Zhang, John H ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Neurology Fifth People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE DISTURBANCE; HEART INJURY; HEMATOLOGIC DISEASE; HORMONE RESPONSE; HUMAN; HYPERGLYCEMIA; KIDNEY DYSFUNCTION; LUNG EDEMA; REVIEW; SUBARACHNOID HEMORRHAGE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; ANTIBODY SPECIFICITY; COMPLICATION; DISEASE MODEL;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; ORGAN SPECIFICITY; SUBARACHNOID HEMORRHAGE;

EID: 84904909346     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/858496     Document Type: Review

References (132)

1. Kingwell K., Stroke: improving the management of patients at risk of haemorrhagic stroke. Nature Reviews Neurology 2014 10, article 1 10.1038/nrneurol.2013.257
2. Li M. H., Chen S. W., Li Y. D., Prevalence of unruptured cerebral aneurysms in Chinese adults aged 35 to 75 years: a cross-sectional study. Annals of Internal Medicine 2013 159 8 514 521
3. Zacharia B. E., Hickman Z. L., Grobelny B. T., DeRosa P., Kotchetkov I., Ducruet A. F., Connolly E. S., Epidemiology of aneurysmal subarachnoid hemorrhage. Neurosurgery Clinics of North America 2010 21 2 221 233 10.1016/j.nec.2009.10.002 2-s2.0-77951059608
4. Chen S., Feng H., Sherchan P., Controversies and evolving new mechanisms in subarachnoid hemorrhage. Progress in Neurobiology 2014 115 64 91
5. Connolly E. S. Jr., Rabinstein A. A., Carhuapoma J. R., Derdeyn C. P., Dion J., Higashida R. T., Hoh B. L., Kirkness C. J., Naidech A. M., Ogilvy C. S., Patel A. B., Thompson B. G., Vespa P., Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012 43 6 1711 1737 10.1161/STR.0b013e3182587839 2-s2.0-84861595790
6. Ostrowski R. P., Zhang J. H., Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage. Translational Stroke Research 2011 2 3 316 327 10.1007/s12975-011-0069-1 2-s2.0-80052267974
7. Shimamura N., Ohkuma H., Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage. Translational Stroke Research 2013 5 3 357 364 10.1007/s12975-013-0310-1
8. Fujii M., Yan J., Rolland W. B., Soejima Y., Caner B., Zhang J. H., Early brain Injury, an evolving frontier in subarachnoid hemorrhage research. Translational Stroke Research 2013 4 4 432 446 10.1007/s12975-013-0257-2 2-s2.0-84879929523
9. Dupont S., Rabinstein A. A., Extent of acute hydrocephalus after subarachnoid hemorrhage as a risk factor for poor functional outcome. Neurological Research 2013 35 2 107 110 10.1179/1743132812Y.0000000122 2-s2.0-84874612156
10. Solenski N. J., Haley E. C. Jr., Kassell N. F., Kongable G., Germanson T., Truskowski L., Torner J. C., Spetzler R. F., Selman W. R., Warf B., Barnett G. H., Solomon R. A., Friedman A. H., Campbell R. L., Horner T., Nauta H. J., Heros R. C., Muizelaar J. P., Mohr G., Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Critical Care Medicine 1995 23 6 1007 1017 10.1097/00003246-199506000- 00004 2-s2.0-0029061064
11. Wybraniec M. T., Mizia-Stec K., Krzych L. J., Neurocardiogenic injury in subarachnoid hemorrhage: a wide spectrum of catecholamine-mediated brain-heart interactions. Cardiology Journal 2014 10.5603/CJ.a2014.0019
12. Davison D. L., Chawla L. S., Selassie L., Tevar R., Junker C., Seneff M. G., Neurogenic pulmonary edema: successful treatment with IV phentolamine. Chest 2012 141 3 793 795 10.1378/chest.11-0789 2-s2.0-84857970735
13. Naredi S., Lambert G., Edén E., Zäll S., Runnerstam M., Rydenhag B., Friberg P., Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000 31 4 901 906 10.1161/01.STR.31.4.901 2-s2.0-0034086307 (Pubitemid 30198436)
14. Fassot C., Lambert G., Elghozi J. L., Lambert E., Impact of the renin-angiotensin system on cerebral perfusion following subarachnoid haemorrhage in the rat. Journal of Physiology 2001 535 2 533 540 10.1111/j.1469-7793.2001.00533.x 2-s2.0-0035449065 (Pubitemid 32825688)
15. Sugimoto K., Inamasu J., Kato Y., Yamada Y., Ganaha T., Oheda M., Hattori N., Watanabe E., Ozaki Y., Hirose Y., Association between elevated plasma norepinephrine levels and cardiac wall motion abnormality in poor-grade subarachnoid hemorrhage patients. Neurosurgical Review 2013 36 2 259 266 10.1007/s10143-012-0424-z 2-s2.0-84880724098
16. Lambert G., Naredi S., Edén E., Rydenhag B., Friberg P., Sympathetic nervous activation following subarachnoid hemorrhage: influence of intravenous clonidine. Acta Anaesthesiologica Scandinavica 2002 46 2 160 165 10.1034/j.1399-6576.2002.460206.x 2-s2.0-0036194386 (Pubitemid 34250777)
17. Inamasu J., Nakamura Y., Saito R., Kuroshima Y., Mayanagi K., Ohba S., Ichikizaki K., Normokalemia and hyperglycemia in subarachnoid hemorrhage patients resuscitated from prehospital cardiopulmonary arrest. Resuscitation 2002 54 3 255 258 10.1016/S0300-9572(02)00122-3 2-s2.0-0036710621 (Pubitemid 35245477)
18. Johansson P. I., Haase N., Perner A., Ostrowski S. R., Association between sympathoadrenal activation, fibrinolysis, and endothelial damage in septic patients: a prospective study. Journal of Critical Care 2014 29 3 327 333 10.1016/j.jcrc.2013.10.028
19. Yeung P. K., Shen J., Chung S. S., Chung S. K., Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage. BMC Neuroscience 2013 14, article 131 10.1186/1471-2202-14-131
20. Bellapart J., Jones L., Bandeshe H., Boots R., Plasma endothelin-1 as screening marker for cerebral vasospasm after subarachnoid hemorrhage. Neurocritical Care 2014 20 1 77 83 10.1007/s12028-013-9887-1 2-s2.0-84880954532
21. MacDonald R. L., Higashida R. T., Keller E., Mayer S. A., Molyneux A., Raabe A., Vajkoczy P., Wanke I., Bach D., Frey A., Nowbakht P., Roux S., Kassell N., Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 2012 43 6 1463 1469 10.1161/STROKEAHA.111.648980 2-s2.0-84861597846
22. Macdonald R. L., Higashida R. T., Keller E., Mayer S. A., Molyneux A., Raabe A., Vajkoczy P., Wanke I., Bach D., Frey A., Marr A., Roux S., Kassell N., Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). The Lancet Neurology 2011 10 7 618 625 10.1016/S1474-4422(11)70108-9 2-s2.0-79958803259
23. Sugimoto K., Inamasu J., Hirose Y., Kato Y., Ito K., Iwase M., Sugimoto K., Watanabe E., Takahashi A., Ozaki Y., The role of norepinephrine and estradiol in the pathogenesis of cardiac wall motion abnormality associated with subarachnoid hemorrhage. Stroke 2012 43 7 1897 1903 10.1161/STROKEAHA.111. 646893 2-s2.0-84863331423
24. Mertes P. M., Carteaux J. P., Jaboin Y., Pinelli G., El Abassi K., Dopff C., Atkinson J., Villemot J. P., Burlet C., Boulange M., Estimation of myocardial interstitial norepinephrine release after brain death using cardiac microdialysis. Transplantation 1994 57 3 371 377 10.1097/00007890-199402150- 00010 2-s2.0-0028296081 (Pubitemid 24086034)
25. Espiner E. A., Leikis R., Ferch R. D., MacFarlane M. R., Bonkowski J. A., Frampton C. M., Richards A. M., The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clinical Endocrinology 2002 56 5 629 635 10.1046/j.1365-2265.2002.01285.x 2-s2.0-0036274875 (Pubitemid 34595731)
26. Berendes E., Walter M., Cullen P., Prien T., Van Aken H., Horsthemke J., Schulte M., Von Wild K., Scherer R., Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. The Lancet 1997 349 9047 245 249 10.1016/S0140-6736(96)08093-2 2-s2.0-0031023210 (Pubitemid 27050991)
27. Papanikolaou J., Makris D., Karakitsos D., Saranteas T., Karabinis A., Kostopanagiotou G., Zakynthinos E., Cardiac and central vascular functional alterations in the acute phase of aneurysmal subarachnoid hemorrhage. Critical Care Medicine 2012 40 1 223 232 10.1097/CCM.0b013e31822e9fab 2-s2.0-84055195106
28. Okuchi K., Fujioka M., Fujikawa A., Rapid natriuresis and preventive hypervolaemia for symptomatic vasospasm after subarachnoid haemorrhage. Acta Neurochirurgica 1996 138 8 951 956
29. Igarashi T., Moro N., Katayama Y., Mori T., Kojima J., Kawamata T., Prediction of symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage: Relationship to cerebral salt wasting syndrome. Neurological Research 2007 29 8 835 841 10.1179/016164107X228624 2-s2.0-37149030402 (Pubitemid 350255158)
30. Kojima J., Katayama Y., Moro N., Kawai H., Yoneko M., Mori T., Cerebral salt wasting in subarachnoid hemorrhage rats: model, mechanism, and tool. Life Sciences 2005 76 20 2361 2370 10.1016/j.lfs.2004.11.010 2-s2.0-14644439958 (Pubitemid 40313423)
31. Fassot C., Lambert G., Gaudet-Lambert E., Friberg P., Elghozi J. L., Beneficial effect of renin-angiotensin system for maintaining blood pressure control following subarachnoid haemorrhage. Brain Research Bulletin 1999 50 2 127 132 10.1016/S0361-9230(99)00089-1 2-s2.0-0032834563 (Pubitemid 29467332)
32. Neil-Dwyer G., Walter P., Shaw H. J. H., Doshi R., Hodge M., Plasma renin activity in patients after a subarachnoid hemorrhage-a possible predictor of outcome. Neurosurgery 1980 7 6 578 582 10.1227/00006123-198012000-00007 2-s2.0-0019185041 (Pubitemid 11210055)
33. Hamann G., Isenberg E., Stoll M., Huber G., Strittmatter M., Schimrigk K., Renin activation correlates with blood amount and distribution in subarachnoid haemorrhage. NeuroReport 1993 4 5 595 598 10.1097/00001756- 199305000-00035 2-s2.0-0027252588 (Pubitemid 23154000)
34. Audibert G., Steinmann G., de Talancé N., Laurens M., Dao P., Baumann A., Longrois D., Mertes P., Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesthesia and Analgesia 2009 108 6 1922 1928 10.1213/ane.0b013e31819a85ae 2-s2.0-66349118314
35. Biancardi V. C., Son S. J., Ahmadi S., Filosa J. A., Stern J. E., Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension 2014 63 3 572 579
36. Pelisch N., Hosomi N., Ueno M., Nakano D., Hitomi H., Mogi M., Shimada K., Kobori H., Horiuchi M., Sakamoto H., Matsumoto M., Kohno M., Nishiyama A., Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in dahl salt-sensitive hypertensive rats. American Journal of Hypertension 2011 24 3 362 368 10.1038/ajh.2010.241 2-s2.0-79951677532
37. Honda Y., Minato H., Fujitani B., Masuda Y., Hosoki K., Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats. Methods and Findings in Experimental and Clinical Pharmacology 1997 19 10 699 706 2-s2.0-0031405574 (Pubitemid 28097271)
38. Simard J. M., Tosun C., Ivanova S., Kurland D. B., Hong C., Radecki L., Gisriel C., Mehta R., Schreibman D., Gerzanich V., Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage. Translational Stroke Research 2012 3 supplement 1 155 165 10.1007/s12975-012-0166-9 2-s2.0-84862248353
39. Commichau C., Scarmeas N., Mayer S. A., Risk factors for fever in the neurologic intensive care unit. Neurology 2003 60 5 837 841 10.1212/01.WNL. 0000047344.28843.EB 2-s2.0-0037432276 (Pubitemid 36297370)
40. Yoshimoto Y., Tanaka Y., Hoya K., Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001 32 9 1989 1993 10.1161/hs0901.095646 2-s2.0-0034834393 (Pubitemid 32868085)
41. Dhar R., Diringer M. N., The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocritical Care 2008 8 3 404 412 10.1007/s12028-008-9054-2 2-s2.0-51449095256
42. Hassen T. A., Pearson S., Cowled P. A., Fitridge R. A., Preoperative nutritional status predicts the severity of the systemic inflammatory response syndrome (SIRS) following major vascular surgery. European Journal of Vascular and Endovascular Surgery 2007 33 6 696 702 10.1016/j.ejvs.2006.12.006 2-s2.0-34247629363 (Pubitemid 46672807)
43. Wartenberg K. E., Schmidt J. M., Claassen J., Temes R. E., Frontera J. A., Ostapkovich N., Parra A., Connolly E. S., Mayer S. A., Impact of medical complications on outcome after subarachnoid hemorrhage. Critical Care Medicine 2006 34 3 617 623 10.1097/01.CCM.0000201903.46435.35 2-s2.0-33644610186
44. Gruber A., Reinprecht A., Illievich U. M., Fitzgerald R., Dietrich W., Czech T., Richling B., Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Critical Care Medicine 1999 27 3 505 514 10.1097/00003246-199903000-00026 2-s2.0-0032962030 (Pubitemid 29162670)
45. Spratt D. E., Reddy V. K., Choxi A. A., Simon S. D., Shay S. D., Davidson M. A., Barr F. E., Summar M. L., Mericle R. A., Dexamethasone significantly attenuates subarachnoid hemorrhage-induced elevation in cerebrospinal fluid citrulline and leukocytes. Journal of Neurosurgical Sciences 2012 56 4 363 371 2-s2.0-84871737276
46. Hocker S. E., Tian L., Li G., Steckelberg J. M., Mandrekar J. N., Rabinstein A. A., Indicators of central fever in the neurologic intensive care unit. JAMA Neurology 2013 70 12 1499 1504
47. Rothoerl R. D., Axmann C., Pina A., Woertgen C., Brawanski A., Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgical Anesthesiology 2006 18 1 68 72 10.1097/01.ana.0000181693.30750.af 2-s2.0-33644874673 (Pubitemid 44491162)
48. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Medicine 2003 29 4 530 538 10.1007/s00134-003-1662-x 2-s2.0-0037396875 (Pubitemid 36523666)
49. Kitamura Y., Nomura M., Shima H., Kuwana N., Kuramitsu T., Chang C., Bando K., Shibata I., Nishikawa H., Acute lung injury associated with systemic inflammatory response syndrome following subarachnoid hemorrhage: a survey by the shonan neurosurgical association. Neurologia Medico-Chirurgica 2010 50 6 456 460 10.2176/nmc.50.456 2-s2.0-77954503858
50. Braunwald E., Kloner R. A., The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982 66 6 1146 1149 10.1161/01.CIR.66.6.1146 2-s2.0-0020414455 (Pubitemid 13238825)
51. Ahmadian A., Mizzi A., Banasiak M., Cardiac manifestations of subarachnoid hemorrhage. Heart, Lung and Vessels 2013 5 3 168 178
52. Ibrahim G. M., MacDonald R. L., Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2012 43 8 2102 2107 10.1161/STROKEAHA.112.658153 2-s2.0-84864286499
53. Skrifvars M. B., Parr M. J., Incidence, predisposing factors, management and survival following cardiac arrest due to subarachnoid haemorrhage: a review of the literature. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012 20, article 75 10.1186/1757-7241-20-75 2-s2.0-84868705151
54. Franco C., Khaled B., Afonso L., Raufi M., Acute subarachnoid hemorrhage and cardiac abnormalities: takotsubo cardiomyopathy or neurogenic stunned myocardium? A case report. Cases Journal 2010 3 81
55. Priebe H. J., Aneurysmal subarachnoid haemorrhage and the anaesthetist. British Journal of Anaesthesia 2007 99 1 102 118 10.1093/bja/aem119 2-s2.0-34447499049 (Pubitemid 47078668)
56. Doshi R., Neil-Dwyer G., Hypothalamic and myocardial lesions after subarachnoid haemorrhage. Journal of Neurology Neurosurgery & Psychiatry 1977 40 8 821 826 10.1136/jnnp.40.8.821 2-s2.0-0017642872 (Pubitemid 8203130)
57. Zaroff J. G., Leong J., Kim H., Young W. L., Cullen S. P., Rao V. A., Sorel M., Quesenberry C. P. Jr., Sidney S., Cardiovascular predictors of long-term outcomes after non-traumatic subarachnoid hemorrhage. Neurocritical Care 2012 17 3 374 381 10.1007/s12028-011-9592-x 2-s2.0-84878189497
58. Brouwers P. J. A. M., Westenberg H. G. M., van Gijn J., Noradrenaline concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid haemorrhage. Journal of Neurology Neurosurgery and Psychiatry 1995 58 5 614 617 10.1136/jnnp.58.5.614 2-s2.0-0029031746
59. Švigelj V., Grad A., Kiauta T., Heart rate variability, norepinephrine and ECG changes in subarachnoid hemorrhage patients. Acta Neurologica Scandinavica 1996 94 2 120 126 10.1111/j.1600-0404.1996.tb07041.x 2-s2.0-0029781315 (Pubitemid 26308798)
60. Chatterjee S., ECG changes in subarachnoid haemorrhage: a synopsis. Netherlands Heart Journal 2011 19 1 31 34 10.1007/s12471-010-0049-1 2-s2.0-79955420229
61. Aydin M. D., Kanat A., Yilmaz A., Cakir M., Emet M., Cakir Z., Aslan S., Altas S., Gundogdu C., The role of ischemic neurodegeneration of the nodose ganglia on cardiac arrest after subarachnoid hemorrhage: an experimental study. Experimental Neurology 2011 230 1 90 95 10.1016/j.expneurol.2010.09.018 2-s2.0-79958034337
62. Schmidt J. M., Crimmins M., Lantigua H., Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage. Neurocritical Care 2014 20 3 390 398 10.1007/s12028-013-9909-z
63. Park S., Kaffashi F., Loparo K. A., Jacono F. J., The use of heart rate variability for the early detection of treatable complications after aneurysmal subarachnoid hemorrhage. Journal of Clinical Monitoring and Computing 2013 27 4 385 393 10.1007/s10877-013-9467-0 2-s2.0-84879549984
64. Chiu T. F., Huang C. C., Chen J. H., Chen W. L., Depressed sympathovagal balance predicts mortality in patients with subarachnoid hemorrhage. The American Journal of Emergency Medicine 2012 30 5 651 656 10.1016/j.ajem.2011.02. 037 2-s2.0-84861916984
65. Schmidt J. M., Sow D., Crimmins M., Albers D., Agarwal S., Claassen J., Connolly E. S., Elkind M. S., Hripcsak G., Mayer S. A., Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage. Neurocritical Care 2014 20 3 382 389 10.1007/s12028-014-9966-y
66. Fukui S., Katoh H., Tsuzuki N., Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage. Critical Care 2003 7 3 R7 R12 10.1186/cc2160
67. Ichinomiya T., Terao Y., Miura K., Higashijima U., Tanise T., Fukusaki M., Sumikawa K., QTc interval and neurological outcomes in aneurysmal subarachnoid hemorrhage. Neurocritical Care 2010 13 3 347 354 10.1007/s12028-010-9411-9 2-s2.0-78649697673
68. Kuroiwa T., Morita H., Tanabe H., Ohta T., Significance of ST segment elevation in electrocardiograms in patients with ruptured cerebral aneurysms. Acta Neurochirurgica 1995 133 3-4 141 146 10.1007/BF01420064 2-s2.0-0028937913
69. Kolin A., Norris J. W., Myocardial damage from acute cerebral lesions. Stroke 1984 15 6 990 993 10.1161/01.STR.15.6.990 2-s2.0-0021717516 (Pubitemid 15175236)
70. Liu Q., Ding Y., Zhang J. H., Lei H., ECG change of acute subarachnoid hemorrhagic patients. Acta Neurochirurgica, Supplementum 2011 111 357 359 10.1007/978-3-7091-0693-8-60 2-s2.0-79960674321
71. Huang C. C., Huang C. H., Kuo H. Y., Chan C. M., Chen J. H., Chen W. L., The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: early risk prognostication. The American Journal of Emergency Medicine 2012 30 5 732 736
72. Shams Y.-H., Insights into the pathogenesis of takotsubo syndrome, which with persuasive reasons should be regarded as an acute cardiac sympathetic disease entity. ISRN Cardiology 2012 2012 6 593735 10.5402/2012/593735
73. Mayer S. A., Lin J., Homma S., Solomon R. A., Lennihan L., Sherman D., Fink M. E., Beckford A., Klebanoff L. M., Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke 1999 30 4 780 786 10.1161/01.STR.30.4.780 2-s2.0-0032892455 (Pubitemid 29156368)
74. Zaroff J. G., Rordorf G. A., Titus J. S., Newell J. B., Nowak N. J., Torchiana D. F., Thomas Aretz H., Picard M. H., Regional myocardial perfusion after experimental subarachnoid hemorrhage. Stroke 2000 31 5 1136 1143 10.1161/01.STR.31.5.1136 2-s2.0-0034069379 (Pubitemid 30253538)
75. King C., Listening to the head and not the heart: subarachnoid haemorrhage associated with severe acute left ventricular failure. BMJ Case Reports 2013 10.1136/bcr-2013-009877
76. Yoneda H., Nakamura T., Shirao S., Tanaka N., Ishihara H., Suehiro E., Koizumi H., Isotani E., Suzuki M., Multicenter prospective cohort study on volume management after subarachnoid hemorrhage: Hemodynamic changes according to severity of subarachnoid hemorrhage and cerebral vasospasm. Stroke 2013 44 8 2155 2161 10.1161/STROKEAHA.113.001015 2-s2.0-84880841334
77. Moussouttas M., Lai E. W., Dombrowski K., Huynh T. T., Khoury J., Carmona G., Decaro M., Pacak K., CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy. Neurocritical Care 2011 14 3 401 406 10.1007/s12028-011-9527-6 2-s2.0-79955870830
78. Mayer S. A., Fink M. E., Homma D., Sherman D., LiMandri G., Lennihan L., Solomon R. A., Klebanoff L. M., Beckford A., Raps E. C., Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology 1994 44 5 815 820 10.1212/WNL.44.5.815 2-s2.0-0028361270 (Pubitemid 24158792)
79. Vannemreddy P., Venkatesh P., Dinesh K., Reddy P., Nanda A., Myocardial dysfunction in subarachnoid hemorrhage: prognostication by echo cardiography and cardiac enzymes. A prospective study. Acta neurochirurgica. Supplement 2010 106 151 154 10.1007/978-3-211-98811-4-27 2-s2.0-73949091093
80. van der Bilt I. A. C., Hasan D., Vandertop W. P., Wilde A. A. M., Algra A., Visser F. C., Rinkel G. J. E., Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology 2009 72 7 635 642 10.1212/01.wnl.0000342471.07290.07 2-s2.0-61849183583
81. Deibert E., Barzilai B., Braverman A. C., Edwards D. F., Aiyagari V., Dacey R., Diringer M., Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. Journal of Neurosurgery 2003 98 4 741 746 10.3171/jns.2003.98.4.0741 2-s2.0-0037380243 (Pubitemid 36396776)
82. Horowitz M. B., Willet D., Keffer J., The use of cardiac troponin-I (cTnI) to determine the incidence of myocardial ischemia and injury in patients with aneurysmal and presumed aneurysmal subarachnoid hemorrhage. Acta Neurochirurgica 1998 140 1 87 93 10.1007/s007010050063 2-s2.0-0031962003 (Pubitemid 28052632)
83. Lin N., Cheng C., Lee Y., Fu Y., Chen J., Ho S., Chiu Y., Early activation of myocardial matrix metalloproteinases and degradation of cardiac troponin i after experimental subarachnoid hemorrhage. Journal of Surgical Research 2013 179 1 E41 E48 10.1016/j.jss.2012.02.008 2-s2.0-84870652753
84. Miss J. C., Kopelnik A., Fisher L. A., Tung P. P., Banki N. M., Lawton M. T., Smith W. S., Dowd C. F., Zaroff J. G., Cardiac injury after subarachnoid hemorrhage is independent of the type of aneurysm therapy. Neurosurgery 2004 55 6 1244 1250 10.1227/01.NEU.0000143165.50444.7F 2-s2.0-10044245124 (Pubitemid 39612861)
85. Radolf S., Smoll N., Drenckhahn C., Dreier J. P., Vajkoczy P., Sarrafzadeh A. S., Cerebral lactate correlates with early onset pneumonia after aneurysmal SAH. Translational Stroke Research 2014 5 2 278 285
86. Schuiling W. J., Dennesen P. J., Rinkel G. J., Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage. Neurocritical Care 2005 3 1 1 10 10.1385/Neurocrit.Care2005;3:1-10 2-s2.0-24644509728 (Pubitemid 41278386)
87. Weir B. K., Pulmonary edema following fatal aneurysm rupture. Journal of Neurosurgery 1978 49 4 502 507 10.3171/jns.1978.49.4.0502 2-s2.0-0018146389 (Pubitemid 9027036)
88. Sato Y., Isotani E., Kubota Y., Otomo Y., Ohno K., Circulatory characteristics of normovolemia and normotension therapy after subarachnoid hemorrhage, focusing on pulmonary edema. Acta Neurochirurgica 2012 154 12 2195 2202 10.1007/s00701-012-1491-1 2-s2.0-84871064136
89. Deehan S. C., Grant I. S., Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine. Intensive Care Medicine 1996 22 7 672 676 10.1007/s001340050150 2-s2.0-0030055383 (Pubitemid 26254277)
90. Vespa P. M., Bleck T. P., Neurogenic pulmonary edema and other mechanisms of impaired oxygenation after aneurysmal subarachnoid hemorrhage. Neurocritical Care 2004 1 2 157 170 10.1385/NCC:1:2:157 2-s2.0-24644515350 (Pubitemid 41278362)
91. Touho H., Karasawa J., Shishido H., Yamada K., Yamazaki Y., Neurogenic pulmonary edema in the acute stage of hemorrhagic cerebrovascular disease. Neurosurgery 1989 25 5 762 768 10.1227/00006123-198911000-00011 2-s2.0-0024385177 (Pubitemid 19265125)
92. Piazza O., Venditto A., Tufano R., Neurogenic pulmonary edema in subarachnoid hemorrage. Panminerva Medica 2011 53 3 203 210 2-s2.0-80054725326
93. Suzuki H., Sozen T., Hasegawa Y., Subarachnoid hemorrhage causes pulmonary endothelial cell apoptosis and neurogenic pulmonary edema in mice. Intracerebral Hemorrhage Research 2011 111 Vienna, Austria Springer 129 132 Acta Neurochirurgica Supplementum 10.1007/978-3-7091-0693-8-21
94. Suzuki H., Sozen T., Hasegawa Y., Chen W., Zhang J. H., Caspase-1 inhibitor prevents neurogenic pulmonary edema after subarachnoid hemorrhage in mice. Stroke 2009 40 12 3872 3875 10.1161/STROKEAHA.109.566109 2-s2.0-73449136109
95. Cobelens P. M., Tiebosch I. A. C. W., Dijkhuizen R. M., van der Meide P. H., Zwartbol R., Heijnen C. J., Kesecioglu J., van den Bergh W. M., Interferon- β attenuates lung inflammation following experimental subarachnoid hemorrhage. Critical Care 2010 14 4, article R157 10.1186/cc9232 2-s2.0-77955816691
96. Chen S., Zhu Z., Klebe D., Role of P2X purinoceptor 7 in neurogenic pulmonary edema after subarachnoid hemorrhage in rats. PLoS ONE 2014 9 2 e89042 10.1371/journal.pone.0089042
97. Alderson P., Gadkary C., Signorini D. F., Therapeutic hypothermia for head injury. Cochrane Database of Systematic Reviews 2004 4 2-s2.0-16644387088
98. Ulvi H., Demir R., Aygul R., Kotan D., Calik M., Aydin M. D., Effects of ischemic phrenic nerve root ganglion injury on respiratory disturbances in subarachnoid hemorrhage: An Experimental Study. Archives of Medical Science 2013 9 6 1125 1131
99. Mutoh T., Kazumata K., Kobayashi S., Terasaka S., Ishikawa T., Serial measurement of extravascular lung water and blood volume during the course of neurogenic pulmonary edema after subarachnoid hemorrhage: initial experience with 3 cases. Journal of Neurosurgical Anesthesiology 2012 24 3 203 208 10.1097/ANA.0b013e318242e52e 2-s2.0-84862530838
100. Gruber A., Reinprecht A., Görzer H., Peter F., Czech T., Illievich U. M., Richling B., Pulmonary function and radiographic abnormalities related to neurological outcome after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 1998 88 1 28 37 10.3171/jns.1998.88.1.0028 2-s2.0-0031964866 (Pubitemid 28018960)
101. Ghosh S., Dey S., Maltenfort M., Vibbert M., Urtecho J., Rincon F., Jallo J., Impact of Hunt-Hess grade on the glycemic status of aneurysmal subarachnoid hemorrhage patients. Neurology India 2012 60 3 283 287 10.4103/0028-3886.98510 2-s2.0-84864454556
102. Badjatia N., Topcuoglu M. A., Buonanno F. S., Smith E. E., Nogueira R. G., Rordorf G. A., Carter B. S., Ogilvy C. S., Singhal A. B., Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Critical Care Medicine 2005 33 7 1603 1609 10.1097/01.CCM.0000168054.60538.2B 2-s2.0-22144475860 (Pubitemid 40980619)
103. Jarhult J., Falck B., Ingemansson S., Nobin A., The functional importance of sympathetic nerves to the liver and endocrine pancreas. Annals of Surgery 1979 189 1 96 100 10.1097/00000658-197901000-00018 2-s2.0-0018340364 (Pubitemid 9122212)
104. Wang Y. Y., Lin S. Y., Chuang Y. H., Sheu W. H., Tung K. C., Chen C. J., Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats. Endocrinology 2014 155 4 1235 1246
105. Kumari S., Anderson L., Farmer S., Mehta S. L., Li P. A., Hyperglycemia alters mitochondrial fission and fusion proteins in mice subjected to cerebral ischemia and reperfusion. Translational Stroke Research 2012 3 2 296 304 10.1007/s12975-012-0158-9 2-s2.0-84861716661
106. Feng W., Tauhid S., Goel S., Sidorov E. V., Selim M., Hyperglycemia and outcome in intracerebral hemorrhage: from bedside to bench-more study is needed. Translational Stroke Research 2012 3 supplement 1 113 118 10.1007/s12975-012- 0163-z 2-s2.0-84862266013
107. Dorhout Mees S. M., van Dijk G. W., Algra A., Kempink D. R. J., Rinkel G. J. E., Glucose levels and outcome after subarachnoid hemorrhage. Neurology 2003 61 8 1132 1133 10.1212/01.WNL.0000090466.68866.02 2-s2.0-0345327733 (Pubitemid 37461953)
108. Alberti O., Becker R., Benes L., Wallenfang T., Bertalanffy H., Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clinical Neurology and Neurosurgery 2000 102 2 78 83 10.1016/S0303-8467(00)00067-6 2-s2.0-0034099298 (Pubitemid 30249259)
109. Naval N. S., Stevens R. D., Mirski M. A., Bhardwaj A., Controversies in the management of aneurysmal subarachnoid hemorrhage. Critical Care Medicine 2006 34 2 511 524 10.1097/01.CCM.0000198331.45998.85 2-s2.0-31344466927 (Pubitemid 43149035)
110. Cort J. H., Cerebral salt wasting. The Lancet 1954 263 6815 752 754 10.1016/S0140-6736(54)92715-4 2-s2.0-50449154795
111. Solomon R. A., Post K. D., McMurty J. G. III, Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery 1984 15 3 354 361 10.1227/00006123-198409000-00010 2-s2.0-0021128751 (Pubitemid 14029950)
112. Fujioka M., Nishio K., Sakaki T., Minamino N., Kitamura K., Adrenomedullin in patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000 31 12 3079 3083 2-s2.0-0034546661
113. Vellimana A. K., Potential implications of HCN channel dysfunction after subarachnoid hemorrhage. Journal of Neuroscience 2012 32 27 9117 9118 10.1523/JNEUROSCI.2064-12.2012 2-s2.0-84863448968
114. Kamp M. A., Dibué M., Schneider T., Steiger H., Hänggi D., Calcium and potassium channels in experimental subarachnoid hemorrhage and transient global ischemia. Stroke Research and Treatment 2012 2012 8 382146 10.1155/2012/382146 2-s2.0-84871827621
115. van den Bergh W. M., Algra A., van der Sprenkel J. W. B., Tulleken C. A. F., Rinkel G. J. E., Hodge C. J. Jr., Awad I. A., Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003 52 2 276 282 10.1227/01.NEU.0000043984.42487.0E 2-s2.0-0037309575 (Pubitemid 36159414)
116. Bradford C. M., Finfer S., O'Connor A., A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage. Critical Care and Resuscitation 2013 15 2 119 125
117. Jeon J. S., Sheen S. H., Hwang G., Kang S. H., Heo D. H., Cho Y., Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Journal of Korean Neurosurgical Society 2012 52 2 75 79 10.3340/jkns.2012.52.2.75 2-s2.0-84867035448
118. Dorhout Mees S. M., Algra A., Vandertop W. P., Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebocontrolled trial. The Lancet 2012 380 9836 44 49 10.1016/S0140-6736(12)60724-7 2-s2.0-84863448272
119. Kudo K., Konta T., Degawa N., Saito S., Kondo R., Kayama T., Kubota I., Relationship between kidney damage and stroke types in Japanese patients. Clinical and Experimental Nephrology 2012 16 4 564 569 10.1007/s10157-012-0594-6 2-s2.0-84865142052
120. Zacharia B. E., Ducruet A. F., Hickman Z. L., Grobelny B. T., Fernandez L., Schmidt J. M., Narula R., Ko L. N., Cohen M. E., Mayer S. A., Connolly E. S., Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study. Stroke 2009 40 7 2375 2381 10.1161/STROKEAHA.108.545210 2-s2.0-67650087937
121. Grassi G., Quarti-Trevano F., Seravalle G., Arenare F., Volpe M., Furiani S., Delloro R., Mancia G., Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011 57 4 846 851 10.1161/HYPERTENSIONAHA.110.164780 2-s2.0-79953177793
122. Schlaich M. P., Socratous F., Hennebry S., Eikelis N., Lambert E. A., Straznicky N., Esler M. D., Lambert G. W., Sympathetic activation in chronic renal failure. Journal of the American Society of Nephrology 2009 20 5 933 939 10.1681/ASN.2008040402 2-s2.0-65649109067
123. Bruderer S., Sasu B., Tsvitbaum N., Dingemanse J., Influence of severe renal impairment on the pharmacokinetics of clazosentan. Journal of Clinical Pharmacology 2011 51 3 413 421 10.1177/0091270010368975 2-s2.0-78650007764
124. Nina P., Schisano G., Chiappetta F., Luisa Papa M., Maddaloni E., Brunori A., Capasso F., Corpetti M. G., Demurtas F., A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage: correlation with hunt-hess grade and outcome. Surgical Neurology 2001 55 4 197 203 10.1016/S0090-3019(01)00402-5 2-s2.0-0035008715 (Pubitemid 32453178)
125. Ilveskero S., Juvela S., Siironen J., Lassila R., D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity. Neurosurgery 2005 57 1 16 24 10.1227/01.NEU.0000163085.48999.D6 2-s2.0-21744435058 (Pubitemid 40944151)
126. Wada K., Makino H., Shimada K., Shikata F., Kuwabara A., Hashimoto T., Translational research using a mouse model of intracranial aneurysm. Translational Stroke Research 2014 5 2 248 251
127. Kaye D. M., Lefkovits J., Cox H., Lambert G., Jennings G., Turner A., Esler M. D., Regional epinephrine kinetics in human heart failure: Evidence for extra-adrenal, nonneural release. The American Journal of Physiology: Heart and Circulatory Physiology 1995 269 1 H182 H188 2-s2.0-0029111593
128. Wartenberg K. E., Mayer S. A., Medical complications after subarachnoid hemorrhage. Neurosurgery Clinics of North America 2010 21 2 325 338 10.1016/j.nec.2009.10.012 2-s2.0-77951042482
129. Macdonald R. L., Jaja B., Cusimano M. D., Etminan N., Hanggi D., Hasan D., Ilodigwe D., Lantigua H., Le Roux P., Lo B., Louffat-Olivares A., Mayer S., Molyneux A., Quinn A., Schweizer T. A., Schenk T., Spears J., Todd M., Torner J., Vergouwen M. D. I., Wong G. K. C., Singh J., SAHIT investigators-on the outcome of some subarachnoid hemorrhage clinical trials. Translational Stroke Research 2013 4 3 286 296 10.1007/s12975-012-0242-1 2-s2.0-84877149778
130. Zygun D. A., Doig C. J., Gupta A. K., Whiting G., Nicholas C., Shepherd E., Conway-Smith C., Menon D. K., Non-neurological organ dysfunction in neurocritical care. Journal of Critical Care 2003 18 4 238 244 10.1016/j.jcrc.2003.10.007 2-s2.0-0346786556 (Pubitemid 38036905)
131. Claassen J., Carhuapoma J. R., Kreiter K. T., Du E. Y., Connolly E. S., Mayer S. A., Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 2002 33 5 1225 1232 10.1161/01.STR.0000015624.29071.1F 2-s2.0-0036094267 (Pubitemid 34520392)
132. Robertson C. S., Valadka A. B., Hannay H. J., Contant C. F., Gopinath S. P., Cormio M., Uzura M., Grossman R. G., Prevention of secondary ischemic insults after severe head injury. Critical Care Medicine 1999 27 10 2086 2095 10.1097/00003246-199910000-00002 2-s2.0-0032748981 (Pubitemid 29508318)